| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 7, 2026
Pharmacy Benefit agreements expand portfolio coverage to simplify access for eligible customers and providers
-
Dec 11, 2025
Results from Australia, Japan and Hong Kong highlight the potential impact across healthcare systems in the Asia-Pacific region
-
Dec 10, 2025
First patient successfully treated by Ajit Rao, MD, at The Mount Sinai Hospital, NY
-
Dec 8, 2025
Onyx™ 18, 34 Liquid Embolic System offers step forward in treatment options for cSDH
-
Dec 4, 2025
Now supported with effectiveness evidence, Medtronic DBS is the first and only U.S. FDA approved system to treat Dystonia symptoms
-
Nov 14, 2025
APHRS.25: Medtronic showcases breadth of defibrillation portfolio with outcomes from extravascular and transvenous defibrillation studies for the treatment of dangerous heart rhythm episodes
-
Nov 10, 2025
Confirmation comes from the position paper published by the Italian Society of Nephrology (SIN), expanding the indication of RDN to a complex and high-risk patient population
-
Oct 30, 2025
Recognition highlights Medtronic design excellence and commitment to improving patient lives
-
Oct 27, 2025
Medtronic also announced completion of enrollment in SPYRAL AFFIRM, which aims to build robust real-world evidence across traditionally underserved patient populations
-
Oct 25, 2025
Stedi Extra Support Guidewire Delivers Enhanced Support for Stability, Safety, and Predictability During Valve Deployment for Aortic Stenosis
-
Oct 21, 2025
Partnership launches AI solution to enhance predictive heart valve visualization and personalize valve treatment planning decisions enabling the future of TAVR for structural heart patients
-
Oct 14, 2025
Avalus Ultra valve expands Medtronic Cardiac Surgery’s portfolio of
cardiac surgical innovations -
Oct 13, 2025
With this labeling approval, Medtronic continues to lead the way in advancing aortic care with clinical evidence for the treatment of ruptured abdominal aortic aneurysms (rAAA). Medtronic plc, a...
-
Oct 10, 2025
Findings highlight the potential of new investigational waveforms for the all-in-one mapping and dual-energy ablation system in advancing treatment for ventricular arrhythmia patients
-
Oct 7, 2025
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5, † Medtronic, a global leader in...


